Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine
Authors
Keywords
-
Journal
Cell Reports
Volume 41, Issue 9, Pages 111729
Publisher
Elsevier BV
Online
2022-11-10
DOI
10.1016/j.celrep.2022.111729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2
- (2022) Hongjie Xia et al. Cell Host & Microbe
- Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
- (2022) John P. Evans et al. Science Translational Medicine
- Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
- (2022) Jing Zou et al. Nature Communications
- Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 + T-Cell Epitopes Identified in COVID-19 Convalescent Individuals
- (2022) Andrew D. Redd et al. mBio
- Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
- (2022) Prerna Arora et al. LANCET INFECTIOUS DISEASES
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
- (2022) Nicole P. Hachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
- (2022) Jing Zou et al. mBio
- A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
- (2022) Yang Liu et al. Nature Communications
- Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
- (2022) Chaitanya Kurhade et al. Nature Communications
- Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
- (2022) Bryan A. Johnson et al. PLoS Pathogens
- Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
- (2022) Chaitanya Kurhade et al. Emerging Microbes & Infections
- Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5
- (2022) Chee-Wah Tan et al. Lancet Microbe
- Evasion of neutralising antibodies by omicron sublineage BA.2.75
- (2022) Daniel J Sheward et al. LANCET INFECTIOUS DISEASES
- Covid-19 Vaccines — Immunity, Variants, Boosters
- (2022) Dan H. Barouch NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
- (2021) Jianying Liu et al. NATURE
- An Infectious cDNA Clone of SARS-CoV-2
- (2020) Xuping Xie et al. Cell Host & Microbe
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started